2 results
Approved WMOCompleted
The objective of this randomised, placebo-controlled trial is to compare a combination of eccentric training and nitroglycerin patches with a combination of eccentric training and placebo patches.
Approved WMOCompleted
In this study we want to determine the activity and safety of concurrent interruption of the MAPK and PI3K pathways by the EGFR tyrosine kinase inhibitor erlotinb and metformin, combined with gemcitabine in patients with metatastatic pancreatic…